There is no FDA-approved BPC-157 and TB-500 dosage for injury. See commonly reported ranges, the wolverine stack protocol, and safety risks. Know the facts.
There is no FDA-approved BPC-157 and TB-500 dosage for injury, because neither peptide is approved for human use in the United States. The numbers most often repeated online come from animal studies, veterinary practice, and self-reported user logs rather than controlled human trials. Commonly cited ranges are 250–500 mcg of BPC-157 once or twice daily and 2–2.5 mg of TB-500 twice weekly, but those figures are not an established medical standard.
Why No Standard Dosage Exists
BPC-157 is a synthetic fragment of a gastric protein, and TB-500 is a synthetic version of thymosin beta-4. Both are sold as research chemicals, and the FDA has not approved either one for treating human injuries.
That matters for dosing. A real prescription dose comes from human clinical trials that establish safety, half-life, and an effective range. No such trials exist for these peptides at the scale regulators require, so any number you see is borrowed from animals or from anecdote.
If you are still asking what is bpc 157 and tb 500 used for, the short answer is that researchers study them for tendon, ligament, muscle, and joint repair, along with wound healing and gut protection. None of those uses are proven in people.
Commonly Reported Dosing Ranges
The table below summarizes protocols that appear repeatedly in research summaries and community reports. Treat it as a description of what people claim, not as a recommendation.
| Peptide | Reported dose | Frequency | Typical duration | Notes |
|---|---|---|---|---|
| BPC-157 | 250–500 mcg | 1–2 times daily | 4–6 weeks | Often injected near the injury; oral capsules also sold |
| TB-500 | 2–2.5 mg | Twice weekly | 4–6 weeks loading | Loading phase often followed by monthly maintenance |
| BPC-157 + TB-500 | Same ranges combined | Daily BPC, biweekly TB | 4–6 weeks | Called a stack; no human trials on the combination |
Some people hunt for a bpc-157 and tb-500 dosage calculator, hoping a formula will settle the question. Body weight, injury location, injection route, and the actual purity of the vial all change the picture, and no calculator has been validated in humans.
TB-500 is usually described with a loading phase, meaning higher and more frequent doses for the first few weeks, followed by a lower maintenance schedule. BPC-157 is typically discussed as a steady daily dose. Neither schedule has been confirmed in peer-reviewed human trials.
The Wolverine Stack: Combining BPC-157 and TB-500
The combination is widely known as the bpc-157 and tb-500 wolverine stack, a nickname borrowed from a comic-book character with rapid healing. The logic is that BPC-157 acts on local tissue repair while TB-500 supports cell migration and tissue flexibility.
In practice, users often run both at the same time, with BPC-157 dosed daily and TB-500 dosed twice weekly. No published human study has tested the pair together, so the combined risks and benefits are largely unknown.
Injection Route and Timing
Most reported protocols use subcutaneous injections, sometimes placed close to the injured area. Others use intramuscular shots, oral capsules, or nasal sprays.
- Subcutaneous: injected into fat tissue, often near the injury site.
- Intramuscular: injected into muscle, sometimes used for deeper injuries.
- Oral: sold as capsules, though peptide absorption through the gut is uncertain.
Timing claims vary. Some reports suggest injecting BPC-157 once in the morning and once at night, and dosing TB-500 on fixed days of the week to keep levels steady.
Does the Injury Type Change the Dose?
Reported protocols shift depending on what is injured, but the supporting evidence stays thin either way.
Tendon and ligament injuries
Tendon and ligament problems are the most common reason people look into these peptides. BPC-157 is often described at 250–500 mcg daily, with TB-500 added at roughly 2 mg twice weekly.
Muscle and back issues
People exploring bpc-157 and tb-500 for back pain usually describe a similar range, sometimes with injections placed near the paraspinal muscles. Muscle strains and partial tears follow the same reported pattern, and no human trial has confirmed any of it.
Safety, Legality, and Product Quality
BPC-157 and TB-500 are not FDA-approved for human use in the United States, and they cannot legally be sold as dietary supplements. Products sold online are typically labeled "for research use only."
Reported side effects include injection-site pain, redness, nausea, dizziness, and headache. Because purity and sterility are not regulated, contaminated or mislabeled vials are a real risk.
Anyone searching for where to buy bpc-157 and tb-500 should read that "research use only" label carefully. It usually means the seller makes no guarantee about human safety, dose accuracy, or sterility.
What to Do Before Considering These Peptides
Talk to a physician or physical therapist about your injury first. Standard care for tendon, ligament, and muscle injuries includes rest, progressive loading, physical therapy, and in some cases prescription anti-inflammatories or corticosteroid injections.
If you decide to use research peptides anyway, keep a few practical points in mind:
- There is no verified human dose, so any protocol is guesswork.
- Get a medical diagnosis before experimenting with unapproved compounds.
- Watch for injection-site reactions and stop if they worsen.
- Tell your doctor about everything you are using, including peptides.
The bottom line: BPC-157 and TB-500 show promise in animal models, but no human trial has established a safe or effective dose for injury. Any specific number, including the common 250–500 mcg and 2–2.5 mg figures, should be treated as unverified.
RELATED PEPTIDE TOPICbody protection compound-157Frequently Asked Questions
What is the typical BPC-157 and TB-500 dosage for injury?
There is no established human dose. Commonly reported ranges are 250–500 mcg of BPC-157 once or twice daily and 2–2.5 mg of TB-500 twice weekly, drawn from animal research and user reports rather than human trials. Neither peptide is FDA-approved for treating injuries in people.
Is the wolverine stack safe?
No human trial has tested BPC-157 and TB-500 together, so the combination's safety profile is unknown. Reported side effects of the individual peptides include injection-site pain, redness, nausea, and headache. Purity and sterility of research-grade vials are not regulated in the United States.
Does BPC-157 and TB-500 help with weight loss?
There is no human evidence that either peptide causes weight loss. They are studied mainly for tissue repair, not for fat loss or metabolic effects. Any weight change reported alongside peptide use is more likely tied to diet and training habits.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.